Cited by 214Vitamin C and Antioxidants ResearchPluripotent Stem Cells ResearchEpigenetics and DNA Methylation

Vitamin C in stem cell reprogramming and cancer

Open access
Cimmino, Luisa, Neel, Benjamin G., Aifantis, Iannis·2018·Trends in Cell Biology

Abstract

Vitamin C is an essential dietary requirement for humans. In addition to its known role as an antioxidant, vitamin C is a cofactor for Fe 2+- and α-ketoglutarate-dependent dioxygenases (Fe 2+/α-KGDDs) which comprise a large number of diverse enzymes, including collagen prolyl hydroxylases and epigenetic regulators of histone and DNA methylation. Vitamin C can modulate embryonic stem cell (ESC) function, enhance reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs), and hinder the aberrant self-renewal of hematopoietic stem cells (HSCs) through its ability to enhance the activity of either Jumonji C (JmjC) domain-containing histone demethylases or ten-eleven translocation (TET) DNA hydroxylases. Given that epigenetic dysregulation is a known driver of malignancy, vitamin C may play a novel role as an epigenetic anticancer agent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tcb.2018.04.001

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For vitamin C to have a therapeutic impact on cancer, it should be given intravenously to achieve plasma levels in mM.

    “For vitamin C to have a therapeutic impact on cancer, it should be given intravenously to achieve plasma levels in mM.”

    From Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination (2021) · cites this paper as [103]

    The “High-dose vitamin C as an anticancer agent” section says IV administration can produce plasma levels up to 30 mM and reports anticancer efficacy with high-dose IV treatment, whereas oral dosing cannot reach those levels. But the claim makes IV delivery sound necessary for any therapeutic impact: the “Vitamin C as an adjuvant for cancer therapy” section also says restoring physiological levels can slow malignant cell growth. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The intracellular concentration of vitamin C should be relatively high for optimal function of 2OGO enzymes since Km for vitamin C ranges from 140 to 300 μM.

    “Moreover, the intracellular concentration of vitamin C should be apparently relatively high for the optimal function of these enzymes since Km for vitamin C ranges from 140 to 300 µM [103].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cimmino, L., Neel, B. G., & Aifantis, I.
Affiliations
NYU Langone’s Laura and Isaac Perlmutter Cancer Center (US)
Corresponding author
  • Cimmino, Luisa
  • Aifantis, Iannis
Venue
Trends in Cell Biology
Publisher
Elsevier BV
Published
2018-09
Volume
28
Issue
9
Pages
698-708
ISSN
0962-8924 (ISSN-L)
OpenAlex
W2801924666
Cited by
197
References
87
Citations by year
2026: 13 · 2025: 13 · 2024: 23 · 2023: 28 · 2022: 29 · 2021: 31 · 2020: 34 · 2019: 20 · 2018: 5
FWCI
2.91
Type
journal article
Language
en
Open access
Locations
  • Trends in Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (R01CA194923, R01CA049152, R01CA149655, R01CA133379, R01CA216421, R01CA169784, R01CA173636, P30CA016087)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
vitamin C, stem cell reprogramming, induced pluripotent stem cells, embryonic stem cells, hematopoietic stem cells, histone demethylase, Jumonji C domain, epigenetic regulation, DNA methylation, histone methylation, cancer epigenetics, fibroblast reprogramming
MeSH terms
Animals, Antioxidants, Ascorbic Acid, Humans, Neoplasms, Stem Cells, Epigenesis, Genetic, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review